General information


Subject type: Basic

Coordinator: Carolina Chabrera Sanz

Trimester: Second term

Credits: 4

Teaching staff: 

Alba Vidal Torres
Lluís Mundet Pons 

Skills


Basic skills
  • CB4_That students can convey information, ideas, problems and solutions to an audience, both specialized and non-specialized

Specific skills
  • CE3_Know the different groups of drugs, the principles of their authorization, use and indication and the mechanisms of action of the same

  • CE4_Use of medicines, evaluating the expected benefits and the associated risks and / or effects derived from their administration and consumption

General competencies
  • CG10_Protect the health and well-being of the people, family or groups cared for, ensuring their safety

  • CG1_To be able, in the field of nursing, to give adequate technical and professional attention to the health needs of the people they care for, in accordance with their state of development of the scientific knowledge of each moment and with the levels of quality and safety that are established in the applicable legal and deontological norms

Transversal competences
  • CT 1 Develop the ability to assess inequalities based on sex and gender, to design solutions

Description


The Pharmacology subject aims to introduce second-year nursing students to the knowledge and use of pharmacological strategies for the treatment of patients.

It is intended that the students know the concepts and general principles essential for the pharmacological treatment of the most frequent diseases in the population. Students must know the beneficial and harmful effects of drugs, their mechanism of action, the risk of interaction with other drugs and food, their use in case of poisoning and their main indications as well as contraindications.

The gender perspective will be an aspect that the teaching staff will take into account by making an inclusive and non-sexist use of language and promoting the equal participation of everyone in an inclusive environment both in master classes and in seminar sessions. The different pharmacological responses in both women and men will become visible. Female bibliographic references will be provided in the classroom to the extent that the subject allows it and the full first name of the authors will be used. Regarding the images of the content in the teaching material, the non-perpetuation of stereotypes will be encouraged.

Learning outcomes


Learning outcomes

LO 17. Identify the different pharmacological families as well as their indications, contraindications, implicit nursing care.

LO 18. Calculate and administer the dosages of prescribed drugs.

LO 19. Interpret the beneficial and adverse pharmacological effects produced by the administration of the different drugs, and respond appropriately to them.

LO 20. Report mistakes and adverse effects.

RA 21. Respect the ethical principles that guarantee the needs of safety, quality and legality.

LO 26. Identify gender deviations in existing knowledge about health-disease processes.

LO 29. Analyze gender differences and gender inequalities in etiology, anatomy, physiology, and pathologies; in differential diagnosis, therapeutic options and pharmacological response, and in prognosis; in caring for people, as well as in other types of diagnoses and health interventions.

 

 

 

 

 

 

 

 

 

 

Working methodology


The subject's methodology will be carried out by combining face-to-face classroom time with independent work time, supported by the virtual learning environment. 

The distribution is distributed as follows:

Working methodologies Methodology Skills
MD1. Plenary exhibition sessions Master classes Classes aimed at debating and clarifying content. Discussion classes of scientific readings CB4, CB5, CE3, CE4, CG1, CG10, CT1
MD2 and MD3. Seminars Group work aimed at analyzing problems using problem-based learning. Preparation and presentation of situations or practical cases. Cooperative learning activities CB4, CB5, CE3, CE4, CG1, CG10, CT1
MD6. Tutorials Face-to-face tutorials in groups or individually CB4, CB5, CE3, CE4, CG1, CG10, CT1
MD11. Self-employment Independent study and work based on reading recommended texts, articles and guides. Study of contents developed in the subject. Preparation of evaluations CB4, CB5, CE3, CE4, CG1, CG10, CT1

 

 

Contents


General pharmacology

Introduction to the subject. Basic principles of pharmacology

Origin and composition of drugs

Research and development of new drugs. Pre-clinical, clinical trials and pharmacovigilance

Medicinal forms of common use

Routes of drug administration

Pharmacokinetics: dynamics of absorption, distribution, metabolism and elimination of drugs

Pharmacodynamics: molecular mechanisms of action of drugs

             Individual drug responses. Pharmacogenetics

             Adverse drug reactions. Allergies and intolerances, toxic effects

             Interactions between drugs and between drugs and food

Endocrine Pharmacology

Blood glucose control: Insulin and hypoglycemics

Thyroid and antithyroid drugs

Pharmacology of the respiratory system

Bronchodilators

Antitussives, mucolytics and expectorants

Cardiovascular and renal pharmacology

Antihypertensives

Pharmacology of heart failure

Antiarrhythmics

Pharmacology of the digestive tract

Antacids and antiemetics

Drugs for gastric motility disorders

Pharmacotherapy of inflammatory bowel disease

Anti-inflammatory and analgesic

Analgesics, antipyretics, non-steroidal anti-inflammatory drugs

Opiates

Antiinfectives

Antibiotics

Antifungals

Antivirals and antiretrovirals

Neuropharmacology

Autonomic nervous system

            Cholinergics and anticholinergics

            Adrenergic and antiadrenergic

Central nervous system

            Neurotransmission

            Antidepressants and anxiolytics

            Antipsychotics

            Opioids and analgesics

            Antiepileptics and anticonvulsants

            Treatment of neurodegenerative diseases

            Hypnotics and sedatives

Pharmacology of hypercholesterolemia

Treatment of hypercholesterolemia and atherosclerosis

Hematopoietic system

Anticoagulants, fibrinolytics and antiplatelets

Hematopoietic and antianemic growth factors

Treatments for intoxications

 

SEMINARS:

They will consist of 3 two-hour sessions where the different concepts learned during the lectures will be worked on in an applied manner.

The resolution of these will have to be delivered according to the pre-established working groups at the beginning of each session.

Learning activities


training activities

Typology Activity

ECTS

HOURS

AF1. Master class

1,2

30

AF6. Teamwork

0,2

5

AF7.Individual work

0,2

5

AF9. Personal study

2,4

60

 

Evaluation system


The evaluation of the subject is continuous, through different tools to assess the different skills needed to pass the subject.

Competencies will be assessed through the following activities:

Evaluation activity Weighting Assessed skills
Individual exam (PEM and short questions) 60% CB4, CB5, CE3, CE4, CG1, CG10, CT1
Questionnaires and individual activities (Moodle) 25% CB4, CB5, CE3, CE4, CG1, CG10, CT1
Group work (seminars) 15% CB4, CB5, CE3, CE4, CG1, CG10, CT1

It is necessary to obtain at least a grade of 5 in the individual exam as an indispensable condition to pass the subject.

The resit assessment will consist of a combined test of multiple-choice questions and short questions similar to the final exam.

As established in article 5 of Royal Decree 1125/2003, the results obtained by the student will be graded according to the numerical scale from 0 to 10, with the corresponding grade:

0 – 4,9: suspension (SS)

5 – 6,9: Pass (AP)

7 – 8,9: remarkable (NT)

9 – 10: excellent (SB)

When the qualification of the subject is of Excellent (mark superior to 9 points) the educational of the asignatura will be able to consider if the student chooses to obtain the qualification of matrícula of honor (MH).

Evaluation activity in recovery period Weighting Assessed skills
Individual final exam: PEM and short questions 60% CB4, CB5, CE3, CE4, CG1, CG10, CT1

The mark obtained from both the seminar part and the questionnaire part will be maintained when calculating the final mark in case of obtaining a mark higher than 5 points out of 10.

In accordance with current regulations, you can only opt for recovery, if it has been suspended the subject. If the rating is Not presented, you will not be eligible for recovery.

The total or partial copy in any of the learning activities will mean a "Not Presented" in the subject, without option to present in the proof of recovery and without prejudice of the opening of a file for this reason.

Bibliography


Basic

Castells Molina, Silvia; Hernandez Perez, Margarita. Pharmacology in nursing. 3rd edition. Elsevier, 2012.

Lorenzo, Pedro; Moreno, Alfonso; Lizasoain, Ignacio; Leza, Juan Carlos; Moro, Maria Ángeles, Portolés, Antonio. Velázquez: Basic and clinical pharmacology. 19th edition. Pan American Medicine, 2018.

Ritter, James M; Flower, Rod J; Henderson, Graeme; Loke, Yoon Kong; MacEwan, David; Rang, Humphrey P. Rang and Dale. Pharmacology 9th edition. Elsevier 2020

Complementary

Armijo, Juan Antonio; Mediavilla, Africa. Human pharmacology. 6th edition, Elsevier Masson, 2014.

Somoza, Beatriz; Cano, Mª Victoria; Guerra, Pedro Enrique. Pharmacology in nursing. Theory and practical cases. Pan American, 2020.